De Sanctis Juan Bautista Ph.D.
Journals
Treatment of Allergic Asthma With Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 ( Ormdl3) Expression and Normalizes Ceramide Imbalance.
The Journal of Pharmacology and Experimental Therapeutics.
2020,
373(3),
476-487,
ISSN: 0022-3565,
PMID: 32273303,
Efficacy of Optimized Treatment Protocol Using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) -Induced Allergic Asthma in Atopic Hyperresponsive A/J Mice.
Pharmacological Research.
2020,
37(2),
31,
ISSN: 0724-8741,
PMID: 31915990,
Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction.
Biochimica et biophysica acta. Molecular and cell biology of lipids.
2019,
1865(2),
158538,
ISSN: 1388-1981,
PMID: 31678518,
Open positions
Project: | Research and development of agents for cancer, neurodegenerative and infectious diseases |
---|---|
Supervisors: | De Sanctis Juan Bautista Ph.D., Hajdúch Marián M.D., Ph.D., Džubák Petr M.D., Ph.D., Urban Milan Ph.D., Das Viswanath M.Sc., Ph.D. |
Available: | 5 |
Intended for: | Doctoral training |